Work

Phase II Trial of Carboplatin, Paclitaxel, Cetuximab, and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Nonsquamous Non–Small-Cell Lung Cancer: SWOG S0536

Year: 2013
Type: article
Study design: Clinical Trial
Language: English
Field: Medicine
Open Access status: bronze
Awards: G1063390784, G117886320, G1188137174, G1205502904, G1216887118, G1343089328, G1375689152, Columbus Community Clinical Oncology Program (Columbus CCOP), G1469275664, G1545560008, G1646027999, G1790576020, G1958973285, G1985252453, G1990518739, G2003196729, G2009210887, G2057923966, G2064543036, Scott & White Community Clinical Oncology Program, G2160369479, G2276667821, G2345882982, G2397742718, G2419449687, G2435896781, G2562936776, G2734683319, G2750730928, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3126600779, G3144944009, G3204966229, UCDCCC NCTN U10 Program, G3239274266, G3242537740, Southeast Cancer Control Consortium, Inc, G3295642875, G3334379738, G3350348941, G3484997517, G3647597407, G36541222, G3710026009, G3717912310, G3737421695, G3792990546, G379387698, G3827208107, G3873422784, G3939550896, G398851121, G4094841028, G413878341, Southwest Oncology Group, G4292856267, G4499432180, G4527800867, G4916734862, G4935167430, G5125348268, G5415431867, G5504618518, G609758592, G6109875642, SOUTHWEST ONCOLOGY GROUP, G6211207823, G6290519354, G6723594983, SOUTHWEST ONCOLOGY GROUP, G6782300252, G691096829, G7061256793, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, G7520596819, G763325562, G7677205365, G7696306938, G774431799, G776903742, G7772521268, G7860541851, G7939453469, G8006406963, G8413228103, G8593264226, G8623336158, G8740717309, G8777682367, G8937348795, University of Colorado Cancer Center Support Grant, G924713883, G937543590, G960417071, G971274320
OpenAlex ID: W2139697170
FWCI: 1.949
Cites: 25
Cited by: 32
Related to: 10